longbridge

Foghorn Therapeutics

FHTX
----

All Shareholders

Shareholder Type

  • Institutions37.34%
  • Hedge funds21.45%
  • VC/PE firms21.34%
  • Individuals & Insiders7.40%
  • Others12.46%

Major Shareholders

Major Shareholders Latest
Shareholder
Flagship Pioneering, Inc
21.34%12.67M0.25%+0
BVF Partners L.P.
14.05%8.35M4.10%+2.50M
FMR LLC
9.61%5.71M0.69%-341.24K
Deerfield Management Company, L.P.
7.40%4.39M0.09%+0
Eli Lilly and Company
6.74%4.00M0.08%+0
Cigall KadochMember of Scientific Advisory Board
6.10%3.62M0.07%+0
BlackRock, Inc.
4.42%2.63M0.40%+261.97K
Raymond James Financial, Inc.
4.19%2.49M0.24%-112.40K
Vanguard Capital Management, LLC
2.96%1.76M<0.01%+23.36K
Euclidean Capital LLC
2.65%1.57M0.03%+0
Geode Capital Management, LLC
1.53%910.87K0.09%+62.69K
Artal Group S.A.
1.21%720.72K0.01%+0
State Street Investment Management
1.17%697.47K0.02%+17.68K
Columbia Management Investment Advisers, LLC
0.94%558.69K0.18%+109.71K
Adrian H. GottschalkPresident, CEO & Director
0.86%511.70K<0.01%+0
Renaissance Technologies LLC
0.64%377.94K0.06%-28.49K
Candriam, Société En Commandite Par Actions
0.53%313.77K<0.01%+0
Northern Trust Global Investments
0.52%309.78K0.05%+33.90K
Jacobs Levy Equity Management Inc
0.51%305.43K<0.01%+1.68K
Vanguard Portfolio Management, LLC
0.51%304.43K0.08%+48.50K
© 2026 Longbridge｜Terms of ServicePrivacy Policy